Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario.

Spagnolo, Calogera Claudia; Giuffrida, Giuseppe; Cannavò, Salvatore; Franchina, Tindara; Silvestris, Nicola; Ruggeri, Rosaria Maddalena; Santarpia, Mariacarmela.

Afiliação

Spagnolo CC; Medical Oncology Unit, Department of Human Pathology "G.Barresi", University of Messina, 98125 Messina, Italy.
Giuffrida G; Endocrinology Unit, Department of Human Pathology of Adulthood and Childhood DETEV, University of Messina, 98125 Messina, Italy.
Cannavò S; Endocrinology Unit, Department of Human Pathology of Adulthood and Childhood DETEV, University of Messina, 98125 Messina, Italy.
Franchina T; Medical Oncology Unit, Department of Human Pathology "G.Barresi", University of Messina, 98125 Messina, Italy.
Silvestris N; Medical Oncology Unit, Department of Human Pathology "G.Barresi", University of Messina, 98125 Messina, Italy.
Ruggeri RM; Endocrinology Unit, Department of Human Pathology of Adulthood and Childhood DETEV, University of Messina, 98125 Messina, Italy.
Santarpia M; Medical Oncology Unit, Department of Human Pathology "G.Barresi", University of Messina, 98125 Messina, Italy.

Cancers (Basel) ; 15(1)2022 Dec 30.

Article em En | MEDLINE | ID: mdl-36612243

Palavras-chave

endocrine-related toxicity; immune checkpoint inhibitors (ICIs); immune-related toxicity; immunotherapy; multidisciplinary treatment; predictive biomarkers

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article